Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Using multiple cards for rewards can significantly boost your benefits. Find out how to optimize your spending for maximum returns.
17,302 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
A director sold about $128,000 of Cognex shares, prompting questions about the stock's outlook. This guide breaks dow...
Greycroft increased its Sportradar stake in a year where the stock fell sharply, illustrating how big investors respo...
As 1stdibs gears up for 2025 earnings, investors crave clarity on growth, profitability, and sustainable margins. Thi...
U.S. M2 hit a fresh high in January 2026, but Bitcoin hasn’t followed the traditional liquidity playbook. Here’s what...
Prediction markets are moving into the mainstream. This piece examines whether Polymarket likely 2026? could bring an...
A sweeping real-world study of roughly 600,000 GLP-1 users finds cravings for cigarettes, alcohol, and other addictio...
When Space Force makes obvious moves to pause launches from Boeing and Lockheed's space venture, investors face a tes...
A near-40 couple with $86,000 in debt is told they can still reach millions in retirement after paying off debt and p...
Berkshire Hathaway just sent a bold signal to the market by resuming share buybacks after a long pause. This article ...
Constellation Energy has closed the Calpine deal and now commands the country’s largest private-sector power fleet, w...
Two tech powerhouses sit at the AI crossroads. This article breaks down the nvidia stock micron stock dynamic, what h...